P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL) - Michael Loschi; Laszlo Rejto; Hun Chuah; Marianna Caramella; Jesus Hernández Rivas; Paolo Sportoletti; Viviane Dubruille; Marcelo Bellesso; Stefanie Gröpper; Carl Crodel; Hope Qamoos; Ashley Socotch; et al. (HemaSphere, 2023)